Hydrochloric Acid

Hydrochloric Acid

SCHEMBL312840

CCCCCCNCC=CCl.Cl

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
S1PR2 known ✓ O95136 5/20 0.37
S1PR4 known ✓ O95977 5/20 0.37
S1PR1 known ✓ P21453 5/20 0.37
S1PR3 known ✓ Q99500 5/20 0.37
S1PR5 known ✓ Q9H228 1/20 0.37
KDM1A O60341 5/20 0.54
TSHR P16473 2/20 0.48
ALDH1A1 P00352 1/20 0.48
EPHX1 P07099 2/20 0.45
ADH1B P00325 2/20 0.45
ADH1C P00326 2/20 0.45
ADH1A P07327 2/20 0.45
ADH7 P40394 2/20 0.45
ADH4 P08319 1/20 0.45
LMNA P02545 1/20 0.37
GNAI3 P08754 1/20 0.37
GNAO1 P09471 1/20 0.37
GNAI1 P63096 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1977774 0.98 KDM1A (0.56) KDM1ATSHRALDH1A1EPHX1ADH1B
Hydrochloric Acid SCHEMBL9052774 0.82
Hydrochloric Acid SCHEMBL28960716 0.81 KDM1A (0.56) KDM1ATSHRALDH1A1EPHX1ADH1B
SCHEMBL8938917 0.80
SCHEMBL24157573 0.78 KDM1A (0.64) KDM1ATSHRALDH1A1EPHX1ADH1B
Hydrochloric Acid SCHEMBL22771740 0.78 TSHR (0.52) KDM1ATSHRALDH1A1EPHX1ADH1B
SCHEMBL22157514 0.78 KDM1A (0.58) KDM1ATSHRALDH1A1EPHX1ADH1B
Hydrochloric Acid SCHEMBL22771700 0.78 KDM1A (0.58) KDM1ATSHRALDH1A1EPHX1ADH1B
Hydrochloric Acid SCHEMBL22771742 0.78 TSHR (0.52) KDM1ATSHRALDH1A1EPHX1ADH1B
SCHEMBL20037699 0.78 KDM1A (0.58) KDM1ATSHRALDH1A1EPHX1ADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 884 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944746-B2 Process for making organic-inorganic hybrid materials MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-04-17 US claimed
US-20140371386-A1 PROCESS FOR MAKING ORGANIC-INORGANIC HYBRID MATERIALS MOMENTIVE PERFORMANCE MATERIALS INC. 2014-12-18 US claimed
WO-2014192037-A1 ANTI-AEROSOL FILTERING ELEMENT, HAVING ANTIMICROBIAL ACTIVITIES, FOR NBC MASKS OFFICINE MECCANICHE GALLI SRL (IT) 2014-12-04 WO claimed
EP-2782965-A1 PROCESS FOR MAKING ORGANIC-INORGANIC HYBRID MATERIALS Momentive Performance Materials Inc. (US) 2014-10-01 EP claimed
WO-2013078450-A1 PROCESS FOR MAKING ORGANIC-INORGANIC HYBRID MATERIALS MOMENTIVE PERFORMANCE MATERIALS, INC. (US) 2013-05-30 WO claimed
WO-2012041658-A1 AQUEOUS RINSE TREATMENT COMPOSITIONS UNILEVER NV (NL) 2012-04-05 WO claimed
US-20100314485-A1 Center-Pull Dispenser for Web Material NATIONAL TISSUE COMPANY LLC 2010-12-16 US claimed
EP-1684623-A4 DISPOSABLE CLEANING HEAD CLOROX CO (US) 2009-02-18 EP claimed
WO-2008081348-A2 METHOD AND COMPOSITION FOR PERMANENTLY SHAPING HAIR THE PROCTER & GAMBLE COMPANY (US) 2008-07-10 WO claimed
US-20080075681-A1 Method and composition for permanently shaping hair PROCTER & GAMBLE COMPANY, THE 2008-03-27 US claimed
WO-1998056429-A1 IMPROVED UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR CONTROL THE PROCTER & GAMBLE COMPANY (US) 1998-12-17 WO claimed
WO-1998056889-A1 FOOD CLEANING COMPOSITIONS CONTAINING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 1998-12-17 WO claimed
WO-1998056888-A1 UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR CONTROL THE PROCTER & GAMBLE COMPANY (US) 1998-12-17 WO claimed
WO-1998056890-A1 UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR AND WRINKLE CONTROL THE PROCTER & GAMBLE COMPANY (US) 1998-12-17 WO claimed
US-4863725-A Novel clear oil-free moisturizer composition SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. 1989-09-05 US claimed
US-4851434-A AMIDE OF DI-, TRI- OR POLYGLYCOL OR GLUCAMINE REACTION PRODUCT WITH D-HYDROXY ACID REVLON CONSUMER PRODUCTS CORPORATION 1989-07-25 US claimed
US-4783333-A Cosmetic containing color particles CHARLES OF THE RITZ GROUP, LTD. (US) 1988-11-08 US claimed
US-4602648-A CATIONIC SPECIES AND/OR PROTEIN SOFT SHEEN PRODUCTS, INC. (US) 1986-07-29 US claimed
US-4482537-A COSMETICS, TOILETRIES CHARLES OF THE RITZ GROUP LTD. (US) 1984-11-13 US claimed
US-4426310-A ETHOXYLATED SULFATE, POLYOXYETHYLENE GLYCOL SORBITAN MONOOLEATE, BETAINE COLGATE-PALMOLIVE COMPANY (US) 1984-01-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080075681-A1 Method and composition for permanently shaping hair AQP3, SLC3A2, SLC27A2 S1PR2 408/4885S1PR4 1168/4885S1PR1 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.